Enovix Corp. (ENVX) intrinsic value & 10-year financials
Enovix Corp. (ENVX) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 7 fiscal years revenue grew 104.0% a year to $31.8M, with an average return on invested capital of -130.2%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $2.49
- Market cap
- $517.0M
- Revenue (FY2025)
- $31.8M
- Revenue growth (7-yr CAGR)
- 104.0%
- ROIC (10-yr avg)
- -130.2%
- Free cash flow (FY2025)
- -$113.5M
ENVX 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $31.8M | -$156.7M | -$0.75 | -$113.5M | -557.0% | -41.2% |
| FY2024 | $23.1M | -$222.2M | -$1.27 | -$184.8M | -1051.7% | -130.9% |
| FY2023 | $7.6M | -$214.1M | -$1.38 | -$166.4M | -3012.2% | -284.8% |
| FY2022 | $0 | -$125.9M | -$1.07 | -$94.9M | — | 138.8% |
| FY2021 | — | — | — | — | — | — |
| FY2020 | $0 | -$39.6M | -$0.49 | -$47.0M | — | -332.7% |
| FY2019 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Enovix Corp revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Enovix Corp has historically struggled to out-earn its cost of capital, averaging just -7.9% ROIC.
Enovix Corp capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Enovix Corp is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-24.91 per share.